The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors

被引:195
作者
Cheung, KMJ
Matthews, TP
James, K
Rowlands, MG
Boxall, KJ
Sharp, SY
Maloney, A
Roe, SM
Prodromou, C
Pearl, LH
Aherne, GW
McDonald, E
Workman, P
机构
[1] Inst Canc Res, Canc Res UK Ctr Canc Therapeut, Sutton SM2 5NG, Surrey, England
[2] Inst Canc Res, Haddow Labs, Sutton SM2 5NG, Surrey, England
[3] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England
基金
英国惠康基金;
关键词
Hsp90; inhibitors; cancer; pyrazole; resorcinol; protein crystal structure;
D O I
10.1016/j.bmcl.2005.05.046
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
High-throughput screening identified the 3,4-diarylpyrazole CCT018159 as a novel and potent (7.1 mu M) inhibitor of Hsp90 ATPase activity. Here, we describe the synthesis of CCT018159 and a number of close analogues together with data on their biochemical properties. Some initial structure-activity relationships are discussed, as well as the crystal structure of CCT018159 bound to Hsp90. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3338 / 3343
页数:6
相关论文
共 58 条
  • [1] AHERNE GW, 2003, METHODS MOL MED NOVE, P149
  • [2] AHERNE GW, 2003, P AM ASSOC CANC RES, V44, P799
  • [3] An efficient "one pot" synthesis of isoflavones
    Balasubramanian, S
    Nair, MG
    [J]. SYNTHETIC COMMUNICATIONS, 2000, 30 (03) : 469 - 484
  • [4] BANERJI U, 2005, IN PRESS J CLIN ONCO
  • [5] Banerji Udai, 2003, Proceedings of the American Association for Cancer Research Annual Meeting, V44, P587
  • [6] The Clinical Applications of Heat Shock Protein Inhibitors in Cancer - Present and Future
    Banerji, Udai
    Judson, Ian
    Workman, Paul
    [J]. CURRENT CANCER DRUG TARGETS, 2003, 3 (05) : 385 - 390
  • [7] 17-(Allylamino)-17-demethoxygeldanamycin activity in human melanoma models
    Burger, AM
    Fiebig, HH
    Stinson, SF
    Sausville, EA
    [J]. ANTI-CANCER DRUGS, 2004, 15 (04) : 377 - 387
  • [8] Hsp90: the vulnerable chaperone
    Chiosis, G
    Vilenchik, M
    Kim, J
    Solit, D
    [J]. DRUG DISCOVERY TODAY, 2004, 9 (20) : 881 - 888
  • [9] Chiosis G, 2003, MOL CANCER THER, V2, P123
  • [10] A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells
    Chiosis, G
    Timaul, MN
    Lucas, B
    Munster, PN
    Zheng, FF
    Sepp-Lorenzino, L
    Rosen, N
    [J]. CHEMISTRY & BIOLOGY, 2001, 8 (03): : 289 - 299